Effect of a 5-HT1 receptor agonist, CP-122,288, on oedema formation induced by stimulation of the rat saphenous nerve
Open Access
- 1 May 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 115 (1) , 1-2
- https://doi.org/10.1111/j.1476-5381.1995.tb16310.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura materBrain Research, 1993
- Effect of a calcitonin gene‐related peptide antagonist (CGRP8–37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerveBritish Journal of Pharmacology, 1993
- The synthesis of a conformationally restricted analog of the anti-migraine drug sumatriptanTetrahedron Letters, 1992
- Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraineTrends in Pharmacological Sciences, 1992
- Pharmacological properties of a potent and selective nonpeptide substance P antagonist.Proceedings of the National Academy of Sciences, 1991
- CP‐93,129, a potent and selective 5‐HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea‐pig dura materBritish Journal of Pharmacology, 1991
- The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura materBritish Journal of Pharmacology, 1990
- Inflammatory oedema induced by synergism between calcitonin gene‐related peptide (CGRP) and mediators of increased vascular permeabilityBritish Journal of Pharmacology, 1985
- Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasationNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979